| Robert Truitt |

President & CEO, HemoCleanse and Ash Access Technology, Inc. Mr. Robert Truitt, a co-founder, serves as the President and CEO of HemoCleanse and Ash Access Technology, Inc (a HemoCleanse spin-off). He is the former President and Chairman of Renal Solutions, Inc. another HemoCleanse spin-off. He was General Partner of Indiana Growth Fund I, Ltd., the initial funding source for Ash Access Technology, Inc. and many other small start-up companies in Indiana.
Mr. Truitt is the former principal consultant with Truitt and Associates, a consulting firm created to facilitate and stimulate entrepreneurship by supplying a wide range of management support to small enterprises and new ventures with a primary focus on applied high technology industries. Mr. Truitt spent the period of 1967 to 1982 holding various positions with the Allen-Bradley Company, Rostone Subsidiary, a custom-engineered molder of fiberglass-reinforced thermoset plastic component parts, where he started as a Project Engineer in 1967 and was promoted to President in 1974. From 1963 to 1965, Mr. Truitt was a Space Guidance Analyst, Apollo Project, with General Motors, on loan to M.I.T. in Cambridge, MA.
Mr. Truitt received B.S. and M.S. degrees in Engineering Science in 1962 and 1963 from Purdue University and an M.B.A. from Harvard University in 1967. He holds a number of affiliations and honors and is a holder of three patents. Mr. Truitt is the husband of Patricia P. Truitt. |